SHALBY2023-04-012023-06-30 SHALBY2023-04-012023-06-30in-bse-fin:OneOperatingExpenses01Member SHALBY2023-04-012023-06-30in-bse-fin:OneOperatingExpenses02Member SHALBY2023-06-30 SHALBY2023-04-012023-06-30in-bse-fin:OneReportableSegmentRevenue01Member SHALBY2023-04-012023-06-30in-bse-fin:OneReportableSegmentRevenue02Member SHALBY2023-04-012023-06-30in-bse-fin:OneReportableSegmentResults01Member SHALBY2023-04-012023-06-30in-bse-fin:OneReportableSegmentResults02Member SHALBY2023-04-012023-06-30in-bse-fin:OneReportableSegmentAssets01Member SHALBY2023-04-012023-06-30in-bse-fin:OneReportableSegmentAssets02Member SHALBY2023-04-012023-06-30in-bse-fin:OneReportableSegmentLiabilities01Member SHALBY2023-06-30in-bse-fin:OneReportableSegmentLiabilities01Member SHALBY2023-04-012023-06-30in-bse-fin:OneReportableSegmentLiabilities02Member SHALBY2023-06-30in-bse-fin:OneReportableSegmentLiabilities02Member SHALBY2023-04-012023-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member SHALBY2023-04-012023-06-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 540797 SHALBY NOTLISTED Shalby Limited Equity 2023-04-01 2024-03-31 2023-07-20 2023-07-13 INR Millions First quarter 13:00:00 14:40:00 2023-07-20 2023-07-20 Not applicable Multi segment 2023-04-01 2023-06-30 Unaudited Consolidated 2354850000.00 45340000.00 2400190000.00 490600000.00 200030000.00 -83690000.00 392010000.00 27540000.00 119410000.00 924600000.00 2070500000.00 329690000.00 0.00 329690000.00 153430000.00 -31910000.00 121520000.00 0.00 208170000.00 0.00 0.00 0.00 0.00 208170000.00 3160000.00 211330000.00 208260000.00 -90000.00 3160000.00 0.00 1073100000.00 10 1.94 1.94 0.00 0.00 1.94 1.94 Notes: 1. The above unaudited financial results for the quarter ended June 30, 2023 have been reviewed by the Audit Committee and subsequently approved by the Board of Directors of the company at their respective meetings held on July 20, 2023. The Statutory Auditors of the Company have carried out a Limited Review for said unaudited financial results. 2. These financial results have been prepared in accordance with Indian Accounting Standards (Ind- AS) as prescribed under section 133 of Companies Act 2013 read with Rule 3 of the Companies (Indian Accounting Standards) Rules 2015 and relevant amendment thereafter. 3. The figures for quarter ended 31st March, 2023 are the balancing figures between the audited figures in respect of the full financial year and the reviewed year-to-date figures up to the third quarter of the respective financial year. 4. Shalby Limited Employees Welfare Trust has acquired 7,00,000 Equity Shares of Shalby Limited pursuant to Employee Stock Option Scheme-2021. During the quarter ended June 30, 2023, the Company has not granted any Stock Options. Till June 30, 2023, Company has granted 2,39,235 Stock Options to eligible employees, out of which total 42,000 Stock Options were lapsed. 5. The consolidated financial result includes the results of the Company and 10 Subsidiary companies (Covering 2 stepdown subsidiaies). The company together with its subsidiaries is herein referred to as the Group . 6. The Company is not a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P /2018/144 dated 26th November, 2018. 7. The Code on Social Security, 2020 ('Code') relating to employee benefits during employment and post-employment benefits has received Presidential assent and has been published in the Gazette of India. However, the effective date of the Code and final rules for quantifying the financial impact are yet to be notified. The Group will assess the impact of the Code when relevant provisions are notified and will record related impact, if any, in the period the Code becomes effective. 8. As per Indian Accounting Standard ( Ind AS ) 108 - Segment Reporting , segment information has been provided in Consolidated Financial Results. The business segments of the company comprise of Healthcare Activities & Manufacturing of Implant. Disclosure for the same is given in the separate note. 9. Previous period figures have been re-grouped, re-cast and re-arranged wherever considered necessary to make it comparable. Fees to Doctors and Consultants 506710000.00 Other expenses 417890000.00 Healthcare Services 2191370000.00 Manufacturing of Implants 163480000.00 2354850000.00 2354850000.00 Healthcare Services 382370000.00 Manufacturing of Implants -52680000.00 329690000.00 329690000.00 Healthcare Services 10465210000.00 Manufacturing of Implants 2330550000.00 12795760000.00 Healthcare Services 1257730000.00 Manufacturing of Implants 2046880000.00 3304610000.00 Items that will not be reclassified to profit or loss 990000.00 990000.00 350000.00 Items that will be reclassified to profit or loss 2520000.00 2520000.00 0.00